Showing results (91-100 of 129) with videos related to
Sort By:
Pageof 13
JCI Insight|May 7, 2024
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient miceZainul S Hasanali, Alfred L Garfall, Lisa Burzenski, et al.Blood|September 7, 2007
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsMonica L Guzman, Randall M Rossi, Sundar Neelakantan, et al.Haematologica|March 10, 2018
Dexamethasone in hyperleukocytic acute myeloid leukemiaSarah Bertoli, Muriel Picard, Emilie Bérard, et al.Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.Cancer Cell|February 23, 2010
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutaratePatrick S Ward, Jay Patel, David R Wise, et al.Leukemia|January 5, 2024
FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemiaPamela J Sung, Murugan Selvam, Simone S Riedel, et al.Plos One|October 26, 2020
Targeted detection and quantitation of histone modifications from 1,000 cellsNebiyu A Abshiru, Jacek W Sikora, Jeannie M Camarillo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.Cancer Discovery|January 27, 2021
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML RecurrenceCihangir Duy, Meng Li, Matt Teater, et al.Nature Medicine|September 19, 2017
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsLy P Vu, Brian F Pickering, Yuanming Cheng, et al.Pageof 13